Pacira | PCRX - Stock


Pacira reported $157.68M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Assertio Holdings USD 24.76M 8.12M Sep/2025
Astellas Pharma JPY 297.26B 9.92B Mar/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Cara Therapeutics USD 900K 0 Mar/2025
Coherus Biosciences USD 2.05M 2.46M Sep/2025
Heron Therapeutics USD 54.57M 2.33M Dec/2022
J&J USD 14.19B 45M Dec/2025
Ligand Pharmaceuticals USD 11.9M 3.59M Sep/2025
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Novo Nordisk DKK 45.65B 21.26B Jun/2025
Omeros USD 712K 266K Sep/2021
Pacira USD 157.68M 9.52M Sep/2025
Perrigo USD 1.23B 11.5M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
Supernus Pharmaceuticals USD 107.1M 63.08M Sep/2025
Teva Pharmaceutical Industries USD 3.18B 144M Dec/2025
Xeris Pharmaceuticals USD 67.46M 182K Sep/2025
Zoetis USD 2.43B 35M Dec/2025